News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
131,182 Results
Type
Article (7601)
Company Profile (57)
Press Release (123521)
Multimedia
Podcasts (21)
Webinars (5)
Section
Business (38465)
Career Advice (89)
Deals (5996)
Drug Delivery (10)
Drug Development (23809)
Employer Resources (12)
FDA (3062)
Job Trends (3590)
News (69215)
Policy (4618)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Standard (1)
Academia (328)
Accelerated approval (12)
Adcomms (13)
Allergies (3)
Alliances (11291)
ALS (21)
Alzheimer's disease (161)
Antibody-drug conjugate (ADC) (247)
Approvals (3217)
Artificial intelligence (166)
Autoimmune disease (50)
Automation (5)
Bankruptcy (55)
Best Places to Work (3303)
BIOSECURE Act (1)
Biosimilars (88)
Biotechnology (50)
Bladder cancer (126)
Brain cancer (46)
Breast cancer (480)
Cancer (3476)
Cardiovascular disease (35)
Career advice (82)
Career pathing (5)
CAR-T (123)
CDC (3)
Cell therapy (261)
Cervical cancer (18)
Clinical research (21216)
Collaboration (669)
Company closure (2)
Compensation (210)
Complete response letters (10)
COVID-19 (352)
CRISPR (25)
C-suite (284)
Cystic fibrosis (8)
Data (2234)
Decentralized trials (1)
Denatured (3)
Depression (11)
Diabetes (38)
Diagnostics (1401)
Digital health (6)
Diversity (2)
Diversity, equity & inclusion (5)
Drug discovery (92)
Drug pricing (25)
Drug shortages (1)
Duchenne muscular dystrophy (27)
Earnings (13937)
Editorial (12)
Employer branding (2)
Employer resources (13)
Events (24861)
Executive appointments (314)
FDA (3893)
Fibrodysplasia Ossificans Progressiva (3)
Frontotemporal dementia (2)
Funding (323)
Gene editing (42)
Generative AI (15)
Gene therapy (89)
GLP-1 (126)
Government (486)
Guidances (87)
Healthcare (4063)
HIV (7)
Huntington's disease (3)
IgA nephropathy (17)
Immunology and inflammation (70)
Immuno-oncology (56)
Indications (51)
Infectious disease (389)
Inflammatory bowel disease (35)
Inflation Reduction Act (3)
Influenza (14)
Intellectual property (54)
Interviews (12)
IPO (2993)
IRA (8)
Job creations (483)
Job search strategy (70)
JPM (25)
Kidney cancer (16)
Labor market (8)
Layoffs (139)
Leadership (6)
Legal (478)
Liver cancer (48)
Longevity (1)
Lung cancer (515)
Lymphoma (222)
Machine learning (14)
Management (3)
Manufacturing (132)
MASH (6)
Medical device (876)
Medtech (880)
Mergers & acquisitions (3259)
Metabolic disorders (104)
Multiple sclerosis (15)
NASH (1)
Neurodegenerative disease (30)
Neuropsychiatric disorders (9)
Neuroscience (317)
NextGen: Class of 2026 (956)
Non-profit (499)
Now hiring (17)
Obesity (58)
Opinion (38)
Ovarian cancer (130)
Pain (27)
Pancreatic cancer (164)
Parkinson's disease (31)
Partnered (1)
Patents (90)
Patient recruitment (152)
Peanut (2)
People (13475)
Pharmaceutical (12)
Pharmacy benefit managers (3)
Phase 1 (8015)
Phase 2 (8873)
Phase 3 (6839)
Pipeline (1625)
Policy (34)
Postmarket research (472)
Preclinical (2532)
Press Release (2)
Prostate cancer (168)
Psychedelics (4)
Radiopharmaceuticals (186)
Rare diseases (142)
Real estate (751)
Recruiting (5)
Regulatory (4755)
Reports (8)
Research institute (696)
Resumes & cover letters (11)
RNA editing (2)
RSV (10)
Schizophrenia (36)
Series A (65)
Series B (29)
Service/supplier (1)
Sickle cell disease (37)
Special edition (3)
Spinal muscular atrophy (16)
Sponsored (6)
Startups (766)
State (1)
Stomach cancer (12)
Supply chain (12)
Tariffs (8)
The Weekly (18)
Vaccines (185)
Venture capital (34)
Weight loss (25)
Women's health (5)
Date
Last 7 days (162)
Last 30 days (583)
Last 365 days (8337)
2026 (804)
2025 (8406)
2024 (9466)
2023 (10639)
2022 (13112)
2021 (13179)
2020 (10961)
2019 (8592)
2018 (6333)
2017 (7122)
2016 (6284)
2015 (6948)
2014 (4524)
2013 (3091)
2012 (3341)
2011 (3329)
2010 (3038)
Location
Africa (88)
Alabama (19)
Alaska (1)
Arizona (25)
Arkansas (2)
Asia (11395)
Australia (1537)
California (3097)
Canada (703)
China (589)
Colorado (81)
Connecticut (128)
Delaware (237)
Europe (20751)
Florida (407)
Georgia (12)
Idaho (6)
Illinois (304)
India (18)
Indiana (99)
Iowa (9)
Japan (205)
Kansas (10)
Kentucky (13)
Maine (4)
Maryland (336)
Massachusetts (2453)
Michigan (26)
Minnesota (109)
Missouri (11)
Montana (7)
Nebraska (2)
Nevada (10)
New Hampshire (10)
New Jersey (879)
New Mexico (3)
New York (740)
North Carolina (235)
Northern California (1637)
Ohio (65)
Oklahoma (1)
Oregon (5)
Pennsylvania (459)
Puerto Rico (2)
Rhode Island (6)
South America (117)
South Carolina (3)
Southern California (1220)
Tennessee (36)
Texas (534)
United States (10455)
Utah (75)
Virginia (24)
Washington D.C. (9)
Washington State (291)
Wisconsin (35)
131,182 Results for "olema oncology".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Olema Oncology to Participate in Upcoming February 2026 Investor Conferences
February 5, 2026
·
1 min read
Press Releases
Olema Oncology Announces Departure of Chief Operating and Financial Officer
February 2, 2026
·
1 min read
Press Releases
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - February 3, 2026
February 4, 2026
·
2 min read
Press Releases
Olema Oncology to Present at 44th Annual J.P. Morgan Healthcare Conference
January 5, 2026
·
1 min read
Press Releases
Olema Oncology to Participate in 8th Annual Evercore Healthcare Conference
November 24, 2025
·
1 min read
Press Releases
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - January 5, 2026
January 6, 2026
·
2 min read
Press Releases
Olema Oncology to Participate in Upcoming November 2025 Investor Conferences
November 3, 2025
·
1 min read
Press Releases
Olema Oncology Reports Third Quarter 2025 Financial and Operating Results
November 10, 2025
·
12 min read
Press Releases
Olema Oncology Announces Pricing of $190.0 Million Public Offering of Common Stock
November 20, 2025
·
4 min read
Press Releases
Olema Oncology Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
November 19, 2025
·
3 min read
1 of 13,119
Next
